{
  "docId": "019de072-f0cb-7745-907c-f9e6b87d2817",
  "docSlug": "e5afd111c5ca3d26ccce5d5b91b81d60",
  "documentTitle": "BioNTech | Investor Day Presentation Deck | 156 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 28,
  "pageCount": 120,
  "prevPage": 27,
  "nextPage": 29,
  "slideType": "other",
  "function": "present_framework",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "The slide uses a hub-and-spoke diagram centered on the BioNTech logo to illustrate the diversity of their technology platforms.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de072-f0cb-7745-907c-f9e6b87d2817/28",
  "deckHref": "/decks/019de072-f0cb-7745-907c-f9e6b87d2817",
  "deckJsonHref": "/decks/019de072-f0cb-7745-907c-f9e6b87d2817.json",
  "deckAnchorHref": "/decks/019de072-f0cb-7745-907c-f9e6b87d2817#slide-28",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.92,
        "x": 0.04,
        "y": 0.18
      },
      "kind": "diagram",
      "text": "Central hub with spokes leading to various therapeutic platforms",
      "attrs": null,
      "subkind": "hub-spoke",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "920a2fb3-671c-461c-92a0-2e89b8e4efe8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.04,
        "y": 0.55
      },
      "kind": "list",
      "text": "Cell & gene therapies: CAR T cells, Individualized TCR therapies, Polyspecific T-cell therapies, In vivo engineered cell therapies",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "220027d3-f825-4e1b-8a40-5cfa6ee53455",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.3,
        "x": 0.04,
        "y": 0.26
      },
      "kind": "list",
      "text": "mRNA vaccines: Individualized cancer vaccines (iNeST), Off-the-shelf cancer vaccines (FixVac), Antigen-specific tolerance vaccines, Prophylactic infectious disease vaccines",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c69ba85-7176-4ad7-8db5-eea9af9cdc26",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.2,
        "x": 0.75,
        "y": 0.55
      },
      "kind": "list",
      "text": "Ribologicals: mRNA-encoded cytokines (RiboCytokines), mRNA-encoded antibodies (RiboMabs), mRNA-encoded lysins (RiboLysins)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "98edf0c0-825b-40ad-b63b-67b1fcab2c4a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.3,
        "x": 0.68,
        "y": 0.26
      },
      "kind": "list",
      "text": "Next-generation immunomodulators: Targeting immune checkpoint molecules, Engineered bispecific antibodies, Engineered mechanisms of action",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c1c80c00-1a67-42a6-9be7-0b883d8785a2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.92,
        "x": 0.04,
        "y": 0.86
      },
      "kind": "paragraph",
      "text": "Multiple product classes with unique combination potential",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "50766839-ea8e-4e9b-9108-b558a6083c91",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.5,
        "x": 0.04,
        "y": 0.05
      },
      "kind": "title",
      "text": "Multi-platform strategy Technology-agnostic innovation engine",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5e0f0b43-b87e-4f02-b28d-f09002cdc305",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Canvas framework",
      "slug": "canvas-framework",
      "agent": null,
      "layer": "slide",
      "matchId": "52708695-1c25-4bd0-b764-76cd6e163ac8",
      "evidence": "Multi-platform strategy: Technology-agnostic innovation engine",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "hub-spoke",
      "slug": null,
      "matchId": "f6fad3d7-34cc-433a-9772-47065fd8b02e",
      "evidence": "Central logo with radiating categories",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 30,
      "from": 10,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "5abee4e9-bad9-4c98-8e0f-028711be24f9",
      "evidence": "The presentation uses the Golden Circle framework to explain the 'why', 'what', and 'how' of BioNTech's mRNA technology",
      "position": 1,
      "objective": "Explain the 'why', 'what', and 'how' of BioNTech's mRNA technology",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}